Great Basin Scientific Inc., a molecular diagnostics company based in Salt Lake City, reported the Journal of Clinical Microbiology published results of a study analyzing the sensitivity and cost effectiveness of the Great Basin Shiga Toxin Direct Test in detecting Shiga Toxin-producing Escherichia coli (STEC) from stool specimens. The results of the study demonstrate an advancement in STEC detection, concluding that the molecular assay from Great Basin provides clinicians with a more cost-effective, rapid and definitive patient diagnosis, when compared to culture and EIA methods, enabling physicians to make more timely decisions on the appropriate course of treatment.

T2 Biosystems Inc., a Lexington, Mass.-based company developing diagnostic products, said that a new study, "Rapid evaluation of platelet function with T2 magnetic resonance," was published in the American Journal of Clinical Pathology. The study supports the use of T2 magnetic resonance technology as a platform with the potential to provide a more sensitive and biologically relevant read-out of platelet dysfunction than traditional diagnostic methodologies, including light transmission aggregometry.

No Comments